BTG Share News (BTG)

BTG Information

There is currently no data for BTG

BTG's emphysema treatment struck down by FDA

Thu, 09th Aug 2018 09:04

(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.The company's Elevair Endobronchial Coil System, which was designed to treat patients suffering severe symptoms, had previously failed to receive backing from the FDA's anaesthesiology and respiratory therapy devices panel of the medical devices advisory committee in June.The company had initially reacted by committing to generating clinical data to support its assessment that had "a role to play" in the management of patients with severe emphysema who had few treatment options.But analysts at Peel Hunt said that investors had likely already written off the London-listed company's product for the US market on account of the earlier failing."As such this news will have little impact on estimates or valuation, but might be a small incremental negative for sentiment as it reinforces the difficulty BTG is experiencing in its attempt to pivot the group to interventional medicine amid the decline of its other two more legacy divisions," Peel said.The coils, which are known as PneumRX Coils in Europe, are designed to be permanently implanted in the most emphysema-damaged parts of the lung to allow more efficient contraction that helps assist the breathing cycle.BTG shares were down 1.90% to 515.00p at 0828 BST.

More News

17 Oct 2016 10:15

Monday broker round-up

(ShareCast News) - Coca Cola Hellenic: Jefferies keeps at buy with a target price of 2100p. Jupiter Fund Management: Societe Generale downgrades to hold, 490p target. Aveva: Barclays keeps at equal-weight with a 1450p target. Arrow Global: Numis upgrades to buy with a 405p target. Close Brothers

6 Oct 2016 15:00

FTSE 250 movers: Gold miner Hochschild leads mid-caps lower

(ShareCast News) - The FTSE 250 retreated further away from its all-time high on Thursday, stung by Brexit worries and investor caution that it may be vulnerable to the reaction to Friday's US non-farm payrolls report. After business group's stressed the importance of immigration to government earli

6 Oct 2016 13:45

BTG lifts revenue guidance on weak sterling

(ShareCast News) - FTSE 250 specialist healthcare group BTG lifted its revenue guidance for the year on the back of the weak pound. In an update for the six months to 30 September, the company said it now expects reported full-year revenue to be ahead of its previously-announced range of £510m to £5

15 Jul 2016 15:00

Friday broker round-up

(ShareCast News) - Ashmore: Goldman Sachs upgrades to buy with a target price of 420p and JP Morgan reiterates underweight with a 250p target. G4S: UBS keeps at buy with a 240p target. Essentra: Jefferies reiterates buy with a 715p target. Playtech: UBS stays at buy with a 1000p target. Aberdeen:

14 Jul 2016 16:06

LONDON MARKET CLOSE: Stocks Mixed But Pound Higher After BoE Stays Put

14 Jul 2016 11:23

LONDON MARKET MIDDAY: Stocks Drop As Bank Of England Waits For August

14 Jul 2016 09:42

WINNERS & LOSERS SUMMARY: SuperGroup Shares Soar On Special Dividend

14 Jul 2016 09:07

BTG loses out on sterling benefit due to hedging and dollar costs

(ShareCast News) - Healthcare company BTG said it would make little gains from the collapse of the pound as its currency hedging contracts would negate the potential revenue benefits from the stronger dollar. The FTSE 250 company, in a statement issued ahead of its annual shareholder meeting and aft

14 Jul 2016 07:28

Latest Share Chat

BTG Share News (BTG)

BTG's emphysema treatment struck down by FDA

Monday broker round-up

FTSE 250 movers: Gold miner Hochschild leads mid-caps lower

BTG lifts revenue guidance on weak sterling

Friday broker round-up

LONDON MARKET CLOSE: Stocks Mixed But Pound Higher After BoE Stays Put

LONDON MARKET MIDDAY: Stocks Drop As Bank Of England Waits For August

WINNERS & LOSERS SUMMARY: SuperGroup Shares Soar On Special Dividend

BTG loses out on sterling benefit due to hedging and dollar costs

LONDON MARKET OPEN: Hays Leads FTSE 250 Gainers Ahead Of BoE Decision

BTG Trades In Line With Expectations, Benefits From Weak Sterling

BROKER RATINGS SUMMARY: Vodafone Cut To Neutral, ITV Raised To Neutral

UK Shareholder Meetings Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

BTG Says US Regulator Approves Shelf Life Extension For Varithena

BROKER RATINGS SUMMARY: Merrill Lynch Upgrades Burberry To Buy

Latest Share Chat

BTG Share News (BTG)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BTG's emphysema treatment struck down by FDA

Login to your account

Quickpicks are a member only feature

Login to your account